Mortgage Blog
Lazydays expands to Ohio
The Ohio location kicks off the beginning of Lazydays’ expansion into the Northeast.
Business bankruptcies continue to climb in Mass.
Business bankruptcies in Massachusetts continue to climb in 2023, as the patience creditors and debtors saw in 2022 starts to wear thin.
Tampa’s Ultimate Medical Academy seeks to fill a ‘basically unending’ need with new acquisition
The merged nonprofit will focus on training health care professionals for hospitals, clinics, pharmacies, doctor’s offices and more.
University of St. Thomas opens third location for accelerated nursing program amid shortage
The University of St. Thomas has opened the third site for its Accelerated Bachelor of Science in Nursing program in Sugar Land. UST also has locations for the ABSN program on its main campus and at a site in Shenandoah.
Biofourmis CEO steps down one month after layoffs
The SoftBank-backed digital therapeutics “unicorn” company confirmed it is conducting a search for a new chief executive after Kuldeep Singh Rajput left his role.
Exclusive: Local health insurance provider discusses the pros and cons of telemedicine
Covid-19 popularized services such as telemedicine. The convenient tool is here to stay, but it has its pros and cons.
Done deal: Globus Medical, NuVasive complete $3B merger
Globus Medical of Audobon and San Diego-based NuVasive have completed their multibillion-dollar merger that unites the two medical device companies.
Under the terms of the all-stock deal valued at about $3 billion, Globus (NYSE: GMED) will issue 0.75 shares of its Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction.
NuVasive shares ceased trading on the Nasdaq as of the close of trading on Aug. 31.
Shares of Globus were trading down…
Dr. Michael Bain, TriHealth’s first chief medical informatics officer, announces exit
Dr. Michael Bain, who served as TriHealth's first-ever chief medical informatics officer, is departing the health system.
Former partner aims to extend Amyris bankruptcy before it toggles to a sale
The company faces a creditor's deadline of mid-September to restructure or face the sale of most of its assets.
Lab Notes: Verrica throws support behind FDA crackdown; Janssen drug targeted for Medicare price negotiations
This week's pharmaceuticals and life sciences industry news includes items on a Chester County pharma firm's skin disease medicine, a local drug that made it on the federal government's initial Medicare drug price negotiation list, and more.